Viracta Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viracta Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Viracta Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -680 %, a 554% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2023 was -146 %, a 116% decline from 2022.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2022 was -67.5 %, a 35.3% increase from 2021.
  • Viracta Therapeutics, Inc. annual Return On Equity for 2021 was -104 %, a 315% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -680 -576 -554% Jul 1, 2024 Sep 30, 2024
Q2 2024 -292 -197 -206% Apr 1, 2024 Jun 30, 2024
Q1 2024 -192 -112 -142% Jan 1, 2024 Mar 31, 2024
Q4 2023 -146 -78.2 -116% Oct 1, 2023 Dec 31, 2023
Q3 2023 -104 -42.1 -68% Jul 1, 2023 Sep 30, 2023
Q2 2023 -95.6 -43 -81.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -79.2 -33.2 -72.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -67.5 +36.8 +35.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -62 +84.4 +57.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -52.6 +203 +79.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -46 +43.5K +99.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -104 -153 -315% Oct 1, 2021 Dec 31, 2021
Q3 2021 -146 -170 -715% Jul 1, 2021 Sep 30, 2021
Q2 2021 -255 -317 -514% Apr 1, 2021 Jun 30, 2021
Q1 2021 -43.6K -43.9K -15448% Jan 1, 2021 Mar 31, 2021
Q4 2020 48.6 +214 Oct 1, 2020 Dec 31, 2020
Q3 2020 23.8 +236 Jul 1, 2020 Sep 30, 2020
Q2 2020 61.6 +504 Apr 1, 2020 Jun 30, 2020
Q1 2020 284 +776 Jan 1, 2020 Mar 31, 2020
Q4 2019 -166 +401 +70.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -212 -18.5 -9.54% Jul 1, 2019 Sep 30, 2019
Q2 2019 -442 -194 -78.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -492 -240 -95.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -567 -290 -105% Oct 1, 2018 Dec 31, 2018
Q3 2018 -194 +101 +34.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -248 +41 +14.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -252 +65.7 +20.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -277 +12.6 +4.34% Oct 1, 2017 Dec 31, 2017
Q3 2017 -295 -16 -5.75% Jul 1, 2017 Sep 30, 2017
Q2 2017 -289 -61.6 -27.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -317 -119 -60% Jan 1, 2017 Mar 31, 2017
Q4 2016 -289 -89.6 -44.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -279 -102 -57.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -228 +42.7 +15.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -198 +102 +33.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -200 +91.6 +31.4% Oct 1, 2015 Dec 31, 2015
Q3 2015 -177 +324 +64.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -270 +285 +51.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -300 +1.57K +84% Jan 1, 2015 Mar 31, 2015
Q4 2014 -291 -1.12K -135% Oct 1, 2014 Dec 31, 2014
Q3 2014 -501 +7.9K +94% Jul 1, 2014 Sep 30, 2014
Q2 2014 -555 +402 +42% Mar 31, 2014 Jun 30, 2014
Q1 2014 -1.87K -1.32K -239% Jan 1, 2014 Mar 31, 2014
Q4 2013 832 +1.23K Oct 1, 2013 Dec 31, 2013
Q3 2013 -8.4K -8.08K -2482% Jul 1, 2013 Sep 30, 2013
Q2 2013 -957 -788 -465% Apr 1, 2013 Jun 30, 2013
Q1 2013 -553 -432 -358% Jan 1, 2013 Mar 31, 2013
Q4 2012 -402 Oct 1, 2012 Dec 31, 2012
Q3 2012 -326 Jul 1, 2012 Sep 30, 2012
Q2 2012 -169 Apr 1, 2012 Jun 30, 2012
Q1 2012 -121 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.